
Gclazid MP 60mg/15mg/500mg Tablet
Marketer
Xenon Pharmaceuticals
Salt Composition
Gliclazide (60mg) + Pioglitazone (15mg) + Metformin (500mg)
Overview Gclazid MP 60mg/15mg/500mg Tablet
Diabex Trio 60mg/15mg/500mg tablets are prescribed for managing type 2 diabetes. This medication assists adults in regulating their blood glucose. Consistent daily intake, ideally with meals at the same time, is crucial. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Discontinuing treatment without medical consultation is strongly discouraged, as it can lead to elevated blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Diabex Trio is part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Maintaining a healthy lifestyle is key to diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, and headaches. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential for prevention. Alcohol consumption should be minimized due to its potential to lower blood sugar. Additional potential side effects include nausea, altered taste, diarrhea, abdominal discomfort, headaches, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe kidney or liver disease. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or breastfeeding women require medical consultation before use. Regular blood sugar checks are necessary, along with potential blood tests to monitor blood cell counts and liver function.
Uses of Gclazid MP 60mg/15mg/500mg Tablet
Managing type 2 diabetes
Major Benefits of Gclazid MP 60mg/15mg/500mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Gclazid MP 60mg/15mg/500mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.
Common Side effects of Gclazid MP 60mg/15mg/500mg Tablet:
- Hypoglycemia (low blood glucose level)
- Dizziness
- Headache
- Nausea
- Vomiting
- Diarrhea
- Flatulence
- Upper respiratory tract infection
- Bronchitis (inflammation of the airways)
- Anemia (low number of red blood cells)
- Edema (swelling)
How to use Gclazid MP 60mg/15mg/500mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. The Gclazid MP 60mg/15mg/500mg Tablet should be administered with a meal.
How Gclazid MP 60mg/15mg/500mg Tablet works:
Gclazid MP 60mg/15mg/500mg tablets combine gliclazide, pioglitazone, and metformin—three distinct antidiabetic agents. This triple-action approach effectively manages blood sugar levels when monotherapy or dual drug regimens prove insufficient. Gliclazide, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose. Pioglitazone, a thiazolidinedione, enhances insulin responsiveness. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Gclazid MP 60mg/15mg/500mg tablets with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Gclazid MP 60mg/15mg/500mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against the risks before prescribing this medication. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Gclazid MP 60mg/15mg/500mg tablets while breastfeeding is likely inadvisable. Available evidence from humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Impaired driving is possible with either hypoglycemia or hyperglycemia. Refrain from driving if these conditions arise.
KidneyUNSAFE
The use of Gclazid MP 60mg/15mg/500mg tablets is likely inadvisable for individuals with impaired kidney function and should be avoided unless specifically directed by a physician. Medical consultation is recommended.
LiverUNSAFE
The use of Gclazid MP 60mg/15mg/500mg tablets is potentially hazardous for individuals with hepatic impairment and should be omitted. Medical advice is recommended.
What if you forget to take Gclazid MP 60mg/15mg/500mg Tablet :
Should you forget a Gclazid MP 60mg/15mg/500mg Tablet dose, take it immediately if possible. Otherwise, near your next scheduled dose, omit the missed one and resume your usual medication regimen. Never take a double dose.
Facts to Know About Gclazid MP 60mg/15mg/500mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
